CDKL5 deficiency disorder – Life with Disease

Go back

CDKL5 deficiency disorder is a rare genetic condition that begins in early infancy, bringing seizures that are hard to control and significant delays in many areas of development. The journey with this disorder affects not only children but their entire families, reshaping daily routines, expectations, and dreams. Understanding what lies ahead can help families navigate this challenging path with greater awareness and preparation.

Prognosis and What to Expect

Learning about the prognosis of CDKL5 deficiency disorder is often one of the most difficult conversations families face. This condition is lifelong, meaning children affected by it will continue to need care and support throughout their lives. The severity of symptoms can vary considerably from child to child, making it hard to predict exactly what any individual’s journey will look like.[1]

Most children with CDKL5 deficiency disorder experience severe intellectual disability and will have little or no speech development. About one-third of affected individuals eventually learn to walk independently, though many others may need mobility assistance throughout their lives. Around half develop purposeful use of their hands, which allows them to interact with objects and communicate in nonverbal ways.[1]

The seizures that characterize this disorder typically persist throughout life. They occur daily in most people with CDKL5 deficiency disorder, though there can be periods when seizures temporarily decrease or stop. Unfortunately, these seizures usually do not respond well to treatment with standard medications, which means families often try multiple approaches to find what works best for their child.[1]

While the disorder is not immediately life threatening, it is complex and affects numerous body systems. Children with CDKL5 deficiency disorder can live into adulthood, though respiratory infections can become serious quickly and require immediate medical attention. The degree of independence each person achieves varies, but most individuals are unable to live independently and require significant, ongoing care and supervision.[15]

⚠️ Important
Some doctors may tell parents that their child will never walk or talk. While it’s true that many children won’t achieve these milestones, some do learn to walk and communicate in various ways. Early therapeutic intervention can be helpful, and it’s important not to set limits before giving your child every opportunity to develop their abilities. Every child is unique, and their potential should not be predetermined.

Natural Progression Without Treatment

Understanding how CDKL5 deficiency disorder unfolds naturally helps families know what changes to watch for over time. The first sign typically appears within the first three months of life, when seizures begin. In most cases, seizures start before the baby is three months old, and about 90 percent of children develop seizures before reaching this age. Some babies experience their first seizure as early as the first week after birth.[2]

The types of seizures change as children grow. What begins as one type of seizure often transforms into different patterns over time, following a somewhat predictable sequence. Common early seizure types include epileptic spasms, which involve short episodes of muscle jerks, tonic seizures, characterized by abnormal muscle contractions, and generalized tonic-clonic seizures, which involve loss of consciousness, muscle rigidity, and convulsions.[1]

Beyond seizures, developmental delays become apparent as infants fail to reach expected milestones. Babies with CDKL5 deficiency disorder often have difficulty with basic motor skills from early on. They may struggle to achieve strong head control, make consistent eye contact, or reach for toys. The condition is called a developmental and epileptic encephalopathy because the brain disorder affects development directly, with seizures adding another layer of challenge.[3]

As children grow, additional symptoms emerge or worsen. Low muscle tone, present from infancy, can lead to orthopedic complications such as scoliosis, a side-to-side curvature of the spine, or hip problems. Over time, some children develop increased muscle tone in their legs, changing from floppy to stiff muscles. Movement problems may include repetitive hand movements like clapping, hand licking, or hand sucking. Other movement disorders such as chorea (involuntary jerky movements) or dystonia (sustained muscle contractions) can also develop.[1][3]

Vision problems are common and often involve cortical visual impairment, meaning the eyes themselves are structurally normal, but the brain has difficulty interpreting what the eyes see. Sleep difficulties typically persist, with children having trouble falling asleep or staying asleep through the night. Feeding challenges often worsen over time due to weakness in the muscles responsible for chewing and swallowing, and many children eventually require a feeding tube to ensure adequate nutrition.[2][15]

Possible Complications

CDKL5 deficiency disorder brings with it the risk of several complications that can significantly affect health and quality of life. Understanding these potential problems helps families recognize warning signs early and seek appropriate care.

Gastrointestinal complications are extremely common. Constipation affects many children and can become severe if not managed properly. Gastroesophageal reflux, where acidic stomach contents flow back into the esophagus, causes discomfort and can damage the esophageal lining over time. These digestive problems, combined with difficulty swallowing, increase the risk of aspiration, which occurs when liquids, food, or saliva enter the lungs instead of the stomach. Aspiration is particularly dangerous because it can lead to serious lung infections.[2][15]

Respiratory infections pose a significant threat to children with CDKL5 deficiency disorder. What might be a minor cold in a typical child can quickly escalate into a life-threatening situation. Viruses affecting the lungs can become serious rapidly, requiring immediate medical attention. Families are advised to seek help right away when respiratory symptoms appear.[15]

Orthopedic complications develop as a result of low muscle tone and limited mobility. Scoliosis can progress and become severe, potentially requiring surgical intervention. Hip dysplasia, where the hip joint doesn’t develop properly or becomes dislocated, is another concern that may need orthopedic management. These skeletal problems can cause pain and further limit mobility.[2]

Seizure-related complications include status epilepticus, a medical emergency where a seizure lasts longer than five minutes or when seizures occur back-to-back without recovery time in between. This condition requires urgent treatment to prevent brain injury.[7]

Growth restriction is common, meaning children may be smaller than expected for their age. Some children also develop microcephaly, an unusually small head size, which reflects impaired brain growth. Episodes of irregular breathing, including periods of very fast or very slow breathing, can occur and may be concerning for families to witness.[1][2]

Impact on Daily Life

Living with CDKL5 deficiency disorder transforms every aspect of daily life, not just for the child but for the entire family. The physical demands of care are substantial and unrelenting.

Daily seizures mean that caregivers must remain constantly vigilant. Families need a Seizure Action Plan so that everyone who cares for the child knows exactly what to do when a seizure occurs. This includes knowing when to call for emergency help, which medications to give, and how to keep the child safe during and after the seizure. The unpredictability of seizures affects the family’s ability to make plans or go places, as medical emergencies can happen at any time.[15]

Sleep deprivation affects the whole household. Because many seizures happen during sleep and children with CDKL5 deficiency disorder often have disrupted sleep patterns themselves, parents frequently go months or even years without adequate rest. This chronic exhaustion takes a toll on physical health, emotional well-being, and the ability to function during the day.[15]

Feeding can take hours each day. Children with swallowing difficulties need careful positioning, specialized techniques, and sometimes thickened liquids or modified food textures. Even with these accommodations, many children require a gastrostomy tube (G-tube), a feeding tube placed directly into the stomach through the abdominal wall. While this ensures adequate nutrition, it requires learning new care skills and managing another aspect of medical care.[2]

Medical appointments consume enormous amounts of time. Children with CDKL5 deficiency disorder need care from multiple specialists, including neurologists for seizures, gastroenterologists for digestive problems, pulmonologists for breathing issues, ophthalmologists for vision concerns, orthopedic specialists for bone and joint problems, physical therapists, occupational therapists, and speech therapists. Coordinating all these appointments, traveling to them, and implementing the recommendations from each specialist becomes a full-time job.[17]

The inability to speak means families must learn to interpret their child’s nonverbal cues to understand what they need or if they’re in pain. Some children learn to use gestures or vocalizations to communicate, while others may benefit from assistive communication devices. However, severe intellectual disability can make it challenging for children to use even adapted communication methods effectively.[6]

Socially, families often become isolated. The intensive care requirements make it difficult to participate in typical family activities, attend social gatherings, or maintain friendships. Siblings may feel neglected as parents’ attention focuses heavily on the affected child’s medical needs. Many families struggle to find caregivers qualified and willing to watch a child with such complex medical needs, making it nearly impossible for parents to have time alone together or pursue personal interests.[21]

Financially, the burden is significant. Even with insurance, the costs of medical equipment, therapies, medications, and frequent hospitalizations add up quickly. Many families find that one parent must stop working to provide full-time care, reducing household income at the same time that expenses are increasing dramatically.

⚠️ Important
Finding your “new normal” with CDKL5 deficiency disorder is an ongoing process, not a destination. Just as families master one stage or challenge, something new often emerges. Self-care for parents and support for siblings are not luxuries—they are necessities for the long-term well-being of the entire family. Connecting with other CDKL5 families through support organizations can provide practical advice, emotional support, and a sense of community that reduces isolation.

Support for Family and Clinical Trials

When a child has CDKL5 deficiency disorder, families need more than just medical care—they need a support system that understands the unique challenges they face. Clinical trials represent an important avenue of hope, offering the possibility of new treatments while contributing to scientific knowledge that may help future generations.

Research is actively ongoing to find treatments and ultimately a cure for CDKL5 deficiency disorder. Several Centers of Excellence dedicated specifically to CDKL5 care and research have been established across the United States and Europe. These specialized centers bring together multidisciplinary teams of experts who focus exclusively on this condition, making it easier for families to coordinate the many aspects of care their child needs.[4][14]

Clinical trials for CDKL5 deficiency disorder are emerging and expanding. These trials test new medications, therapies, and approaches to managing symptoms. One significant milestone was the approval of the first targeted treatment for seizures associated with CDKL5 deficiency disorder, demonstrating that disease-specific therapies are possible. Additional trials are investigating genetic therapies and other innovative approaches.[4]

Families considering clinical trial participation should know that these studies require specific eligibility criteria, which might include the child’s age, genetic test results showing the specific type of CDKL5 mutation, seizure frequency, and other health conditions. Not every child will qualify for every trial, but staying informed about opportunities is important. Parents can ask their child’s neurologist or other specialists about current and upcoming trials, or they can contact CDKL5 Centers of Excellence directly.[17]

Preparing a child for potential trial participation involves several practical steps. Families should maintain organized medical records, including copies of genetic testing results showing the specific CDKL5 mutation, detailed seizure logs with information about frequency and types of seizures, lists of all medications tried and their effects, and comprehensive documentation of developmental milestones and abilities. Having this information readily available makes it easier to determine if a child qualifies for a particular study.[4]

The International CDKL5 Disorder Database collects information from families worldwide to help researchers understand the natural history of the condition—how it typically progresses and how different symptoms manifest across diverse individuals. Contributing to this database, even if a child isn’t in a clinical trial, advances scientific understanding and helps researchers design better studies. This collaborative research network connects Centers of Excellence with families globally.[4]

Beyond clinical trials, families benefit from practical support resources. Parent support matching programs connect newly diagnosed families with experienced CDKL5 families who can offer guidance, answer questions, and provide emotional support from the unique perspective of having walked the same path. Online communities allow families from around the world to share experiences, strategies, and encouragement.[4]

Advocacy work represents another way families can contribute. By raising awareness of CDKL5 deficiency disorder, families help ensure that more doctors recognize the condition, that more resources are directed toward research, and that policies supporting families with rare diseases improve. Some family members become active in fundraising efforts that directly support research initiatives.

Educational resources help families understand complex medical information and learn care techniques. Resource libraries offered by CDKL5 organizations provide guides on topics ranging from managing seizures at home to understanding genetic testing results to navigating insurance and obtaining necessary medical equipment. These materials are designed to be accessible to people without medical backgrounds.[4]

Finding good medical providers who will collaborate with families is crucial. Parents are encouraged to prepare lists of questions and concerns before appointments, to insist on clear explanations they can understand, and not to hesitate asking doctors or therapists to explain concepts in different ways if something isn’t clear. Families are their child’s best advocates, and building partnerships with responsive, knowledgeable medical professionals makes an enormous difference in the quality of care.[15]

Finally, families should remember that they didn’t cause CDKL5 deficiency disorder. The genetic mutation happens spontaneously in most cases and is not passed down through families. Nothing done during pregnancy caused this condition, and nothing could have prevented it. This is not anyone’s fault, and releasing any guilt is an important step in moving forward with the care and advocacy their child needs.[4]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Ztalmy® (ganaxolone) – The first and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder in patients two years of age and older. It is a liquid anti-seizure medication taken daily that significantly reduced major motor seizure frequency in clinical trials.

Ongoing Clinical Trials on CDKL5 deficiency disorder

  • Study on the Effectiveness and Safety of Fenfluramine Hydrochloride for Patients with CDKL5 Deficiency Disorder

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Germany Ireland Italy The Netherlands +2
  • Study on Long-Term Safety of Soticlestat for Adults and Children with Developmental Epileptic Encephalopathies

    Not recruiting

    2 1 1
    Investigated drugs:
    Poland Portugal Spain

References

https://medlineplus.gov/genetics/condition/cdkl5-deficiency-disorder/

https://www.childrenshospital.org/conditions/cdkl5-disorder

https://www.ncbi.nlm.nih.gov/books/NBK602610/

https://www.cdkl5.com/about-cdkl5

https://www.childrenscolorado.org/conditions-and-advice/conditions-and-symptoms/conditions/cdkl5-deficiency-disorder/

https://www.chop.edu/conditions-diseases/cdkl5-deficiency-disorder

https://www.childneurologyfoundation.org/disorder/cdkl5-deficiency-disorder/

https://pmc.ncbi.nlm.nih.gov/articles/PMC10801578/

https://jneurodevdisorders.biomedcentral.com/articles/10.1186/s11689-021-09384-z

https://www.cdkl5.com/about-cdkl5

https://www.childrenscolorado.org/conditions-and-advice/conditions-and-symptoms/conditions/cdkl5-deficiency-disorder/

https://www.childrenshospital.org/conditions/cdkl5-disorder

https://pmc.ncbi.nlm.nih.gov/articles/PMC11145618/

https://my.clevelandclinic.org/pediatrics/services/cdkl5-deficiency-disorder-treatment

https://www.cdkl5.com/guide/living-with-cdkl5

https://www.childrenscolorado.org/conditions-and-advice/conditions-and-symptoms/conditions/cdkl5-deficiency-disorder/

https://my.clevelandclinic.org/pediatrics/services/cdkl5-deficiency-disorder-treatment

https://pmc.ncbi.nlm.nih.gov/articles/PMC11145618/

https://www.chop.edu/stories/cdkl5-deficiency-disorder-averys-story

https://www.childneurologyfoundation.org/disorder/cdkl5-deficiency-disorder/

https://www.cdkl5.com/guide/finding-your-new-normal

https://www.childrenshospital.org/conditions/cdkl5-disorder

FAQ

How is CDKL5 deficiency disorder diagnosed?

Diagnosis is initially suspected based on symptoms like early seizures, developmental delays, and physical examination findings. Confirmation requires a genetic test, which is a simple blood test that identifies mutations in the CDKL5 gene. Your child’s doctor must order this genetic testing, and most children are already under the care of a neurologist or geneticist when the test is performed.

How common is CDKL5 deficiency disorder?

CDKL5 deficiency disorder is rare, affecting approximately 1 in 40,000 to 60,000 live births. Despite being rare, it is considered one of the most common forms of genetic epilepsy. About 90 percent of those diagnosed are girls, though boys can also be affected.

Will my child’s seizures ever be controlled?

Seizures in CDKL5 deficiency disorder are notoriously difficult to control and usually do not respond well to standard anti-seizure medications. A reasonable goal is to manage seizures rather than completely stop them. The FDA has approved ganaxolone (Ztalmy®) specifically for seizures associated with CDKL5 deficiency disorder in patients two years and older. Many families try multiple medications, ketogenic diet, and sometimes other approaches to find what provides the best seizure control for their child.

Is CDKL5 deficiency disorder inherited from parents?

In most cases, no. The CDKL5 gene mutation is usually “de novo,” meaning it occurs spontaneously as a new mutation in the child’s genes and is not inherited from the parents. However, there have been rare cases reported where multiple siblings in a family were affected with the same genetic variant. Nothing parents did during pregnancy caused this condition, and nothing could have prevented it.

Can my child participate in clinical trials?

Clinical trials for CDKL5 deficiency disorder are emerging and expanding, testing new medications and therapies. Whether your child qualifies depends on specific eligibility criteria for each trial, including factors like age, specific genetic mutation, seizure frequency, and other health conditions. Ask your child’s neurologist about current trials or contact a CDKL5 Center of Excellence to learn about opportunities. Keeping organized medical records helps determine eligibility more easily.

🎯 Key takeaways

  • CDKL5 deficiency disorder is a lifelong condition affecting approximately 1 in 40,000 to 60,000 births, making it one of the most common forms of genetic epilepsy despite being rare.
  • The first FDA-approved treatment specifically for CDKL5-related seizures (ganaxolone/Ztalmy®) became available in 2022, marking a significant milestone after the gene was only identified in 2004.
  • Seizures in CDKL5 deficiency disorder typically begin within the first three months of life and occur daily in most affected individuals, with types of seizures changing as children grow.
  • About one-third of children with CDKL5 deficiency disorder learn to walk independently, and roughly half develop purposeful hand use—outcomes that vary widely from child to child.
  • Respiratory infections can quickly become life-threatening in children with CDKL5 deficiency disorder and require immediate medical attention.
  • CDKL5 Centers of Excellence provide specialized multidisciplinary care and coordinate clinical trials, making it easier for families to access expert care and participate in research.
  • The genetic mutation causing CDKL5 deficiency disorder is usually spontaneous (de novo) and is not inherited from parents—nothing done during pregnancy caused or could have prevented it.
  • Scientists do not yet know the full spectrum of CDKL5 disorders, and there are likely people with mild symptoms and no seizures who have never been diagnosed, making continued research and awareness crucial.